drug

berdazimer

1 story · latest Aug 13, 2026

Status: FDA approved Jan 2024 · NDA217424
Brand: Zelsuvmi

Timeline

Pelthos posts second quarter 2026 results as Zelsuvmi revenue climbs

Aug 13Quarterly updateberdazimer Pelthos Therapeutics Inc.

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.